Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Annexin 1: differential expression in tumor and mast cells in human larynx cancer

Full text
Author(s):
Silistino-Souza, Rosana ; Rodrigues-Lisoni, Flávia C. ; Cury, Patricia M. ; Maniglia, José V. ; Raposo, Luis S. ; Tajara, Eloiza H. [6] ; Christian, Helen C. ; Oliani, Sonia M.
Total Authors: 8
Document type: Journal article
Source: International Journal of Cancer; v. 120, n. 12, p. 2582-2589, June 2007.
Field of knowledge: Biological Sciences - Genetics
Abstract

Annexin 1 protein (ANXA1) expression was evaluated in tumor and mast cells in human larynx cancer and control epithelium. The effect of the exogenous ANXA1 (peptide Ac 2-26) was also examined during the cellular growth of the Hep-2 human larynx epidermoid carcinoma cell line. This peptide inhibited the proliferation of the Hep-2 cells within 144 hr. In surgical tissue specimens from 20 patients with larynx cancer, ultrastructural immunocytochemistry analysis showed in vivo down-regulation of ANXA1 expression in the tumor and increased in mast cells and Hep-2 cells treated with peptide Ac2-26. Combined in vivo and in vitro analysis demonstrated that ANXA1 plays a regulatory role in laryngeal cancer cell growth. We believe that a better understanding of the regulatory mechanisms of ANXA1 in tumor and mast cells may lead to future biological targets for the therapeutic intervention of human larynx cancer. (AU)